BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frodsham AJ. Host genetics and the outcome of hepatitis B viral infection. Transpl Immunol. 2005;14:183-186. [PMID: 15982561 DOI: 10.1016/j.trim.2005.03.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: A meta-analysis. World J Gastroenterol 2012; 18(24): 3119-3128 [PMID: 22791948 DOI: 10.3748/wjg.v18.i24.3119] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
2 Wasityastuti W, Yano Y, Ratnasari N, Triyono T, Triwikatmani C, Indrarti F, Heriyanto DS, Yamani LN, Liang Y, Utsumi T. Protective effects of HLA-DPA1/DPB1 variants against Hepatitis B virus infection in an Indonesian population. Infect Genet Evol. 2016;41:177-184. [PMID: 27051043 DOI: 10.1016/j.meegid.2016.03.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
3 Qiu B, Wang X, Zhang P, Shi C, Zhang J, Qiu W, Wang W, Li D. Association of TNF-α promoter polymorphisms with the outcome of persistent HBV infection in a northeast Chinese Han population. Acta Biochim Biophys Sin (Shanghai). 2012;44:712-718. [PMID: 22695741 DOI: 10.1093/abbs/gms046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
4 Jiang X, Zhang B, Zhao J, Xu Y, Han H, Su K, Tao J, Fan R, Zhao X, Li L, Li MD. Identification and characterization of SEC24D as a susceptibility gene for hepatitis B virus infection. Sci Rep 2019;9:13425. [PMID: 31530870 DOI: 10.1038/s41598-019-49777-8] [Reference Citation Analysis]
5 Qiu B, Huang B, Wang X, Liang J, Feng J, Chang Y, Li D. Association of TAP1 and TAP2 polymorphisms with the outcome of persistent HBV infection in a northeast Han Chinese population. Scand J Gastroenterol 2012;47:1368-74. [PMID: 22989262 DOI: 10.3109/00365521.2012.725090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
6 den Hartog JE, Morré SA, Land JA. Chlamydia trachomatis-associated tubal factor subfertility: Immunogenetic aspects and serological screening. Hum Reprod Update 2006;12:719-30. [PMID: 16832042 DOI: 10.1093/humupd/dml030] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
7 Koziel MJ, Thio CL. Hepatitis B Virus and Hepatitis Delta Virus. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 2059-86. [DOI: 10.1016/b978-0-443-06839-3.00146-6] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
8 Lin CL, Kao JH. Recent advances in the treatment of chronic hepatitis B. Expert Opin Pharmacother. 2011;12:2025-2040. [PMID: 21682661 DOI: 10.1517/14656566.2011.590474] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
9 Xu T, Zhu A, Sun M, Lv J, Qian Z, Wang X, Wang T, Wang H. Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma. Oncotarget 2018;9:96-109. [PMID: 29416599 DOI: 10.18632/oncotarget.22941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
10 Cui MF, Gao YF, Lv F, Li N, Zhang ZH, Li X, Su F. Association between polymorphisms of the T cell immunoglobulin musin-3 gene and outcome of hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 2011; 19(14): 1506-1510 [DOI: 10.11569/wcjd.v19.i14.1506] [Reference Citation Analysis]
11 Li JR, Li JG, Deng GH, Zhao WL, Dan YJ, Wang YM, Chen S. A common promoter variant of TBX21 is associated with allele specific binding to Yin-Yang 1 and reduced gene expression. Scand J Immunol. 2011;73:449-458. [PMID: 21272048 DOI: 10.1111/j.1365-3083.2011.02520.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
12 Panassié L, Borentain P, Nafati C, Bernardin G, Doudier B, Thibault V, Gerolami R, Colson P. Fatal fulminant primary hepatitis B virus infections with G1896A precore viral mutants in southeastern France. Clin Res Hepatol Gastroenterol 2012;36:e1-8. [PMID: 22037043 DOI: 10.1016/j.clinre.2011.09.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li N, Gao YF, Zhang TC, Chen P, Li X, Su F. Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection. World J Hepatol 2012; 4(3): 105-109 [PMID: 22489263 DOI: 10.4254/wjh.v4.i3.105] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
14 He YL, Zhao YR, Zhang SL, Lin SM. Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol 2006; 12(30): 4788-4793 [PMID: 16937459 DOI: 10.3748/wjg.v12.i30.4788] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
15 Keeffe EB, Dieterich DT, Han SB, Jacobson IM, Martin P, Schiff ER, Tobias H. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update. Clinical Gastroenterology and Hepatology 2008;6:1315-41. [DOI: 10.1016/j.cgh.2008.08.021] [Cited by in Crossref: 315] [Cited by in F6Publishing: 289] [Article Influence: 22.5] [Reference Citation Analysis]
16 Zeng Z, Liu H, Xu H, Lu H, Yu Y, Xu X, Yu M, Zhang T, Tian X, Xi H, Guan L, Zhang J, O'Brien SJ; HBVstudy consortium. Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression. BMC Med Genomics 2021;14:84. [PMID: 33736632 DOI: 10.1186/s12920-021-00907-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Howell JA, Visvanathan K, Kowdley K, Mccaughan G, Trautwein C. A novel role for human leukocyte antigen-DP in chronic hepatitis B infection: A genomewide association study. Hepatology 2009;50:647-9. [DOI: 10.1002/hep.23147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
18 Park GH, Kim KY, Cheong JY, Cho SW, Kwack K. Association of GNLY genetic polymorphisms with chronic liver disease in a Korean population. DNA Cell Biol. 2012;31:1492-1498. [PMID: 22788687 DOI: 10.1089/dna.2012.1709] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
19 Liu L, Yao J, Li J, Zhang J, Yu J, Jiang X, Sun S, Liu Q, Chang Y, He Y, Lin J. Effects of variant rs346473 in ARHGAP24 gene on disease progression of HBV infection in Han Chinese population. J Huazhong Univ Sci Technolog Med Sci 2011;31:482. [PMID: 21823009 DOI: 10.1007/s11596-011-0477-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Härtel C, Schultz C, Herting E, Göpel W. Genetic association studies in VLBW infants exemplifying susceptibility to sepsis--recent findings and implications for future research. Acta Paediatr 2007;96:158-65. [PMID: 17429897 DOI: 10.1111/j.1651-2227.2007.00128.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
21 Ülger Y, Bayram S, Sandıkçı MÜ, Akgöllü E, Bekar A. Relationship between programmed cell death-1 polymorphisms and clearance of hepatitis B virus. Int J Immunogenet 2015;42:133-9. [PMID: 25736598 DOI: 10.1111/iji.12187] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
22 Jiang H, Cao F, Cao H, Rao Q, Yang Y. Associations of human leukocyte antigen and interleukin-18 gene polymorphisms with viral load in patients with hepatitis B infection. Medicine (Baltimore) 2018;97:e11249. [PMID: 30045250 DOI: 10.1097/MD.0000000000011249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Vermehren J, Lötsch J, Susser S, Wicker S, Berger A, Zeuzem S, Sarrazin C, Doehring A. A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers. PLoS One 2012;7:e32605. [PMID: 22448225 DOI: 10.1371/journal.pone.0032605] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
24 Zhang K, Pan X, Shu X, Cao H, Chen L, Zou Y, Deng H, Li G, Xu Q. Relationship between MIF-173 G/C polymorphism and susceptibility to chronic hepatitis B and HBV-induced liver cirrhosis. Cell Immunol 2013;282:113-6. [PMID: 23770720 DOI: 10.1016/j.cellimm.2013.04.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
25 Kao JH. HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon? Liver Int. 2014;34 Suppl 1:112-119. [PMID: 24373087 DOI: 10.1111/liv.12400] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
26 Lin C, Tseng T, Su T, Liu C, Chen P, Lai M, Chen D, Kao J. Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission. Hepatol Int 2012;6:598-605. [DOI: 10.1007/s12072-011-9297-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Jiang X, Ma Y, Cui W, Li MD. Association of variants in HLA-DP on chromosome 6 with chronic hepatitis B virus infection and related phenotypes. Amino Acids 2014;46:1819-26. [DOI: 10.1007/s00726-014-1767-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
28 Hennig BJ, Hall AJ. Host genetic factors in hepatitis B infection, liver cancer and vaccination response: a review with a focus on Africa. Sci Total Environ 2012;423:202-9. [PMID: 20970823 DOI: 10.1016/j.scitotenv.2010.09.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
29 Zhang W, Lv F, Gao YF, Zou GZ, Pan FM, Li X. Association between BTLA polymorphisms and genetic susceptibility to chronic HBV infection. Shijie Huaren Xiaohua Zazhi 2015; 23(15): 2373-2381 [DOI: 10.11569/wcjd.v23.i15.2373] [Reference Citation Analysis]
30 Zhao XM, Gao YF, Zhou Q, Pan FM, Li X. Relationship between interleukin-6 polymorphism and susceptibility to chronic hepatitis B virus infection. World J Gastroenterol 2013; 19(40): 6888-6893 [PMID: 24187466 DOI: 10.3748/wjg.v19.i40.6888] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
31 Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41:591-595. [PMID: 19349983 DOI: 10.1038/ng.348] [Cited by in Crossref: 375] [Cited by in F6Publishing: 363] [Article Influence: 28.8] [Reference Citation Analysis]
32 Laaribi AB, Zidi I, Hannachi N, Ben Yahia H, Chaouch H, Bortolotti D, Zidi N, Letaief A, Yacoub S, Boudabous A, Rizzo R, Boukadida J. Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis. J Viral Hepat 2015;22:835-41. [PMID: 25619305 DOI: 10.1111/jvh.12395] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
33 Cui JJ, Zeng Z, Tian GB, Tian D, Lu HY. Advance in genetic factors influencing hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 2007; 15(11): 1246-1251 [DOI: 10.11569/wcjd.v15.i11.1246] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Yan Z, Tan S, Dan Y, Sun X, Deng G, Wang Y. Relationship between HLA-DP gene polymorphisms and clearance of chronic hepatitis B virus infections: case-control study and meta-analysis. Infect Genet Evol. 2012;12:1222-1228. [PMID: 22543033 DOI: 10.1016/j.meegid.2012.03.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
35 Tong S, Liu G, Li M, Li X, Liu Q, Peng H, Li S, Ren H, Yin W. Natural killer cell activation contributes to hepatitis B viral control in a mouse model. Sci Rep 2017;7:314. [PMID: 28331190 DOI: 10.1038/s41598-017-00387-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
36 Lv F, Gao YF, Zhang ZH, Zhang TC, Pan FM, Cui MF, Xia SL, Li X, Yin HF. Polymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients. World J Hepatol 2011; 3(3): 72-78 [PMID: 21487538 DOI: 10.4254/wjh.v3.i3.72] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
37 Ben Selma W, Alibi S, Smach MA, Saad A, Boukadida J. IL-18 variant increases risk of enhanced HBV DNA replication in chronic hepatitis. Immunology Letters 2020;228:70-5. [DOI: 10.1016/j.imlet.2020.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Al-saffar OB, Bajlan JS, Ad'hiah AH. Association analysis of interleukin-1 single nucleotide polymorphisms in viral hepatitis of Iraqi patients. Meta Gene 2019;20:100546. [DOI: 10.1016/j.mgene.2019.100546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Zhang C, He Y, Shan KR, Tan K, Zhang T, Wang CJ, Guan ZZ. Correlations between polymorphisms in the uridine diphosphate-glucuronosyltransferase 1A and C-C motif chemokine receptor 5 genes and infection with the hepatitis B virus in three ethnic groups in China. J Int Med Res 2018;46:739-51. [PMID: 29239247 DOI: 10.1177/0300060517730174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]